Search
for
Sort by
Research 61–90 of 160
- Psychoactive drugs and skin
- Herbal Treatment for Dermatologic Disorders
- Hair loss
- Controversies in off‐label prescriptions in dermatology: the perspective of the patient, the physician, and the pharmaceutical companies
- Role of ciclosporin in steroid-responsive sudden sensorineural hearing loss
- COVID‐19, androgens, and androgenic alopecia
- Adverse cutaneous effects of psychotropic medications
- Cutaneous Markers of Disorders Affecting Adult Horses
- Immunosuppressive therapy in autoimmune disease — A review
- Ottawa, Ontario, Canada, February 13–16, 2013
- Excess granulation tissue and hair loss following acitretin
- Issues in the Treatment of Epilepsy
- Cutaneous Reactions to Drugs
- Cytokines
- Triple-Negative Sjogren’s Syndrome and Recurrent Pneumothorax: An Uncommon Presentation of Autoimmune Disease
- Immune-Mediated Skin Reactions Induced by Recombinant Antibodies and Other TNF-Alpha Inhibitors
- Diaminodiphenyl Sulfone-Induced Hemolytic Anemia and Alopecia in a Case of Linear IgA Bullous Dermatosis
- Mnemonics in dermatology
- Folliculotropic mycosis fungoides in a child: a rare case
- WARFARIN-INDUCED ALOPECIA: A RARE CASE REPORT
- Current systemic treatment strategies for hidradenitis suppurativa
- Antihelminthic Drugs
- Compounding as a Current Therapeutic Option in Dermatology
- Pyodermatitis vegetans associated with multiple myeloma
- Perspectives on Dermatopathology
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Human pluripotent stem cell-derived skin organoids enabled pathophysiological model of Mycobacterium tuberculosis infection
- Overexpression of HE4/WFDC2 gene in mice leads to keratitis and corneal opacity
- Trichological disorders in organ transplant recipients (OTRs): a literature review
- Necrobiosis lipoidica of the scalp